These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4506104)

  • 21. Insulin activates the appearance of insulin-like growth factor II receptors on the adipocyte cell surface.
    Oka Y; Mottola C; Oppenheimer CL; Czech MP
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4028-32. PubMed ID: 6330732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further characterization of growth hormone-dependent somatomedin-binding proteins in rat serum and demonstration of somatomedin-binding proteins produced by rat liver cells in culture.
    Moses AC; Nissley SP; Passamani J; White RM
    Endocrinology; 1979 Feb; 104(2):536-46. PubMed ID: 446374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a somatomedin (insulin-like growth factor) synthesized by fetal rat liver organ cultures.
    Rechler MM; Eisen HJ; Higa OZ; Nissley P; Moses AC; Schilling EE; Fennoy I; Bruni CB; Phillips LS; Baird KL
    J Biol Chem; 1979 Aug; 254(16):7942-50. PubMed ID: 468799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of food and GH on the binding of 125I-somatomedin A to the membranes of rat lung and kidney.
    Takano K; Kogawa M; Asakawa K; Hasumi Y; Shizume K
    Endocrinol Jpn; 1981 Oct; 28(5):669-75. PubMed ID: 7344952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The purification and partial characterization of human somatomedin C.
    Liberti JP; Miller MS
    J Biol Chem; 1980 Feb; 255(3):1023-9. PubMed ID: 7356647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity.
    Herington AC; Kuffer AD
    Biochem J; 1984 Oct; 223(1):89-96. PubMed ID: 6388566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone and somatomedin.
    Hall K; Luft R
    Adv Metab Disord; 1974; 7(0):1-36. PubMed ID: 4606597
    [No Abstract]   [Full Text] [Related]  

  • 28. The somatomedin group of peptide growth factors.
    Van Wyk JJ; Furlanetto RW; Plet AS; D'Ercole AJ; Underwood LE
    Natl Cancer Inst Monogr; 1978 May; (48):141-7. PubMed ID: 748748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatomedin.
    Hall K; Van Wyk JJ
    Curr Top Exp Endocrinol; 1974; 2():155-78. PubMed ID: 4829867
    [No Abstract]   [Full Text] [Related]  

  • 30. Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor.
    King GL; Kahn CR; Rechler MM; Nissley SP
    J Clin Invest; 1980 Jul; 66(1):130-40. PubMed ID: 6995478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal regulation of somatomedin secretion by fetal rat hepatocytes in primary culture.
    Richman RA; Benedict MR; Florini JR; Toly BA
    Endocrinology; 1985 Jan; 116(1):180-8. PubMed ID: 3871085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatomedin: inhibiton of adenylate cyclase activity in subcellular membranes of various tissues.
    Tell GP; Cuatrecasas P; Van Wyk JJ; Hintz RL
    Science; 1973 Apr; 180(4083):312-5. PubMed ID: 4700595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of insulin-like growth factor I/somatomedin-C with cultured rat chondrocytes: receptor binding and internalization.
    Schalch DS; Sessions CM; Farley AC; Masakawa A; Emler CA; Dills DG
    Endocrinology; 1986 Apr; 118(4):1590-7. PubMed ID: 3004923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human plasma fractions inhibit the action of insulin on adipocytes and somatomedin on cartilage.
    Avasthy N; Khokher MA; Taylor AM; Dandona P
    Diabetologia; 1986 Jul; 29(7):453-6. PubMed ID: 3527845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Demonstration of the presence of an ultrafiltrable substance in human serum activating somatomedin A].
    Heulin MH; Artur M; Straczek J; Malaprade D; Pierson M; Stoltz JF; Belleville F; Paysant P; Nabet P
    C R Seances Soc Biol Fil; 1981; 175(3):364-71. PubMed ID: 6456047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of somatomedin titers of normal and hypopituitary sera by addition of L-triiodothyronone in vitro at physiological concentrations.
    Audhya TK; Gibson KD
    Proc Natl Acad Sci U S A; 1975 Feb; 72(2):604-8. PubMed ID: 123643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The binding of rat liver cell multiplication-stimulating activity (MSA) to human placenta and serum proteins.
    Brinsmead MW; Liggins GC
    Aust J Exp Biol Med Sci; 1978 Oct; 56(5):527-44. PubMed ID: 36062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum.
    Moses AC; Nissley SP; Short PA; Rechler MM; White RM; Knight AB; Higa OZ
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3649-53. PubMed ID: 6932040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of a somatomedin from plasma of rats bearing growth hormone secreting tumors.
    Chochinov RH; Mariz IK; Daughaday WH
    Endocrinology; 1977 Feb; 100(2):549-56. PubMed ID: 188631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Insulin receptors-a review (author's transl)].
    Freychet P
    Diabete Metab; 1975 Mar; 1():57-68. PubMed ID: 791721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.